CBR Biotech Strategies GmbH

General information
CBR Biotech Strategies GmbH
Tegeler Straße 7
13353 Berlin, Berlin
Germany

Contact person: Jeanne M. Novak, CEO and Principal Consultant
Company main phone: +49 (30) 208473620
Company main fax:  +49 (30) 208473621
Website:  https://cbrbiotech.com
Year founded:2013
Source of foundation: Other
Corporate description / mission:
CBR Biotech Strategies GmbH specialized in the development and E.U. representation for biotech, pharmaceutical and medical device companies. The company's initial service offerings include filing clinical trial authorizations (CTA) to run EU trials and marketing application authorizations (MAA). CBR Biotech Strategies GmbH also acts as the authorized representative to serve as a point-of-contact with EU member states’ competent authorities (CA).
State of ownership: Private / independent
Headquarters: No
Remarks on ownership / listings
CBR Biotech Strategies GmbH was founded in 2013 as a partner company of CBR International Corp., USA (founded in 2002).
In 2023, CBR International has joined Novotech.
Categorization
Sector:
  • Professional Services and Consulting
Subsector:
  • Drug development consulting
  • Information provider
  • Management consulting
  • Regulatory Affairs
Business model:
  • Service company
  • Subsidiary
Customer segments:
  • Large biotech & big pharma
  • Small biotech
Summary Products / Services / Technologies
Description of products:
Services:
European regulatory representative services
Regulatory consulting & strategy
Corporate strategy
Executive training & development, etc.
Collaborations & Clients
Partnering strategy / collaborations:
CBR International Corp.®
TruSubmit LLC
© 2023 Biotechgate by Venture Valuation
X